Dissertatsia_DG_Semenikhina

281

562. Claussen, B. Health and Re-employment in a Two-year Follow up of Longtermed Unemployed / B. Claussen, A. Bjorndal, P. F. Hjort // Epidemiology,

Community Health. ― 1993. ― Vol. 47. ― №1. ― P. 14―18.

563. Conrad, K. Das Problem der Nosologishen Einheitin der. / K. Conrad //

Psychiatric Nervonazzt. ― 1959. ― №11. ― S. 486―496.

564. Corrigan, P. W. The Social Perceptual Delicits of Schizophrenia / P. W.

Corrigan // Psychiatry. ― 1997. ― Vol. 60. ― P. 309―326.

565.Coton, C. L. Young Chronic Schizophrenics and Substance Abuse / C. L. Coton, A. Gralnick // J. Hosp. Psychiatry. ― 1989. ― Vol. 40. ― P. 1037―1040.

566.Crumpton, E. How Patient Normal See the Mental Patients / E. Crumpton, A.

D.Weinstein, C. W. Acker // J. Clin. Psychol. ― 1967. ― Vol. 23. ― P. 46―49.

567. Czcrnansky, J. Double-blind Comparison of Alprasolam, Diazepam and Placebo for the Treatment of Negative Schizophrenia Symptoms / J. Czcrnansky, Sh. Rincy, L.

Lombroso, J. Overall, L. Hollister // Arch. Gen. Psychiatry. ― 1988. ― Vol. 45. ― №7. ― P. 655―659.

568. Daherty, M. M. Affective Reactiviti of Symptoms as a Process Discriminotor in

Schizophrenia / M. M. Daherty // J. Nerv. Ment. Dis. ― 1996. ― №9. ― P. 53―54. 569. David, A. S. Callosal transfer in schizophrenia to much or to little / A. S. David //

J. Abnormal Psychol. ― 1993. ― Vol. 102. ― P. 573―579.

570. Davis, J. M. Use of survival curves in analisis of antipsychotic relapse studies / J. M. Davis, M. W. Dysken, S. J. Haberman, J. Javaid, S. Chang, G. Killian // Amer. J.

Psychiaty. ― 1980. ― Vol. 39. ― Р. 32―39.

571. Day, D. C. A Comparison of Patients and Prescribers´ Believes about

Neuroleptic Side Effects Prevalence, Distress and Causations / D. C. Day, P.

Kinderman, R. A. Bentall // Acta Psich. Scand. ― 1998. ― Vol. 97. ― P. 394―397. 572. Defede, J. A. Acute Intrusive and Avoidant Symptoms of Chronic PTSD following Burn Injury / J. A. Defede, D. Barokas // J. Traumatic Stress. ― 1999. ― Vol. 12. ― №2. ― P. 203―210.

282

573. De Leon, J. Why do Some Psychiatric Patients Somatize / J. de Leon, J. Saiz-

Rutz, A. Chinchilla, P. Morales // Acta Psychiatr. Scand. ― 1987. ― №2. ― P. 203―209.

574. De List, L. E. Speech Disorder in Schizophrenia Review of Literature and Exploration of its Relation to the Uniquely Human Capacity for Languade / L. E. De

List // Schizophr. Bull. ― 2001. ― Vol. 27. ― Р. 481―496.

575. De Montigny, C. The effect of mirtrazapine on the interactions beyween central noradreniergic and serotonergi systems/ C. de Montigny, N. Haddjeri, R. Mongeau, P.

Blier // CNS Drugs. ― 1995. ― Vol. 4. ― Suppl 1. ― P. 13―17.

576.Diamond, R. J. Enhancing Medication Use in Schizophrenic Patient / R. J. Diamond // J. Clin. Psychiatry. ― 1983. ― Vol. 44. ― P. 253―261.

577.Di Costanzo, F. L abuss di Farmaci Anticolnergici in Uno Popalazione di Schizophrenici: review clinice ed epidemiologii / F. Di Costanzo, E. Schifano //

Neuropsychopharmacology. ― 1988. ― Vol. 10. ― №4. ― P. 163―166.

578. Dietz, P. E. Battery Incidents and Batterers in Maximum Security Hospital / P. E.

Dietz, R. T. Rada // Arch. Gen. Psychiatr. ― 1982. ― №11. ― P. 409―410. 579. Dixon, L. Acute Effects of Drug Abuse in Schizophrenic Patients: Clinical

Observatorions and Patients Self-report / L. Dixon, G. Haas, R. Weiden, J. Swiney, A.

Frances // Schizophrenia Bull. ― 1990. ― Vol. 16. ― №1. ― P. 69―79.

580. Donohoe, G. Predictors of Compliance with Neuroleptic Medication among inpatients with Schizophrenia: a Discriminant function analisis /G. Donohoe // Eur.

Psychiatry. ― 2001. ― №5. ― Р. 293―298.

581.Donald, C. G. Перспективы лечения когнитивного дефицита и негативных симптомов шизофрении / C .G. Donald // Всемирная психиатрия. Официальный журнал ВПА. ― Июнь 2013. ― С. 95―102.

582.Dowman, R. Spinal and Supraspinal Correlation of Noception of Men / R.

Dowman // Pain. ― 1991. ― Vol. 45. ― P. 269―281.

583. Duer, A. R. Informed Consent and the Psychiatric Patients / A. R. Duer, S.

Bloch // J. Med. Ethics. ― 1987. ― Vol. 13. ― №1. ― P. 12―13.

283

584. Ebel, H. Basic symptoms in schizophrenic and affective psychoses / H. Ebel, G.

Gross, J. Klosterkotter, G. Huber // Psychopathology. ― 1989. ― Vol. 22. ― №4. ― P. 224―232.

585. Edelman, R. J. Anxicty-Theory, Research and Intervention in Clinical and Healts

Psychology. ― New-York : Wiley Press, 1992. ― 121p.

586. Edvards, I. R. Adverse drug reactions: definition, diagnosis, and management / I.

R. Edvards, J. K. Aronson // Lancet. ― 2000. ― Vol. 356. ― Р. 332―335.

587. Edwards, D. W. Does Patient Satisfaction Correlate with Success / D. W.

Edwards, R. M. Yarvis, D. P. Mueller, D. G. Longsley // Hosp. Commun. Psychiatr. ― 1978. ― №3. ― P. 188―190.

588. Engel, G. The Need for a New Medical Model A Change for Biomedicine / G.

Engel // Science. ― 1977. ― Vol. 196. ― P. 129―136.

589.Falkai, P. Loss of Sylvion Fissure Asymmetry in Schizophrenia. A Guantitative Post Morten Stydy / P. Falkai, B. Bogerts, A. Klinischmidt, H. Steinsmetz, Th. Schneider, B. Grive, K. Pilz // Schizophr. Res. ― 1994. ― Vol. 7. ― P. 23―32.

590.Fanous, A. Relationship Between Positive and Negative Symptoms of Schizophrenia and Schizotypal Symptoms in Nonpsychotic Relatives / A. Fanous, Ch.

Gardner, D. Walsh, K. S. Kendler // Archives of General Psychiatry. ― 2001. ― Vol. 58. ― P. 669―673.

591. Fennig, S. The Effect of Trihexiphenidil (Artane) on Memory in Schizophrenic Patients / S. Fennig, Y. Yosi, N. Silvana, E. Avner // Progr. Neuropsychopharmacol. and Biol. Psychiat. ― 1987. ― Vol. 11. ― №11. ― P. 77―78.

592. Fenton, W. S. Determinants of Medication Compliance in Schizophrenia: Empiral and Clinical Findings / W. S. Fenton, C. R. Blyler, R. K. Heinssen // Schizophr. Bull.

― 1997. ― Vol. 23. ― №4. ― Р. 637―652.

593. Filipp, S. H. Kritische Lebensereignisse / S. H. Filipp. ― Weinheim: Beltz

Psychologic Verlags Union, 1990. ― 147 s.

284

594.Fioritti, A. Heavy Cigarette Smoking and Polidipsial Induced by Neuroleptic Medication? / A. Fioritti / /Eur. Psychiatry. ― 1997. ― Vol.12. ― №3. ― P. 156―158.

595.Fleischhacker, W. W. The pharmacologic treatment of neuroleptic-induced akathisia / W. W. Fleischhacker, S. D. Roth, J.M. Kane // J. Clin. Psychopharmacol. ― 1990. ― №10. ― Р. 12―18.

596.Fowler, D .G. Psychological Aspects of the Functional Psychoses / D. G. Fowler

// Current Opinion in Psychiatry. ― 1990. ― №3. ― P. 800―809.

597. Franke, A. G. Gesundheit – ein Begriff im Spectrum der Wertsysteme / A.

Franke // Praxis der Klinischen Verhaltensmedizin und Rehobilitation. ― 1990. ― №12. ― S. 313―320.

598. Freedman, A. M. The Biopsychosocial Paradigm And The Future Psychiatry / A. M. Freedman // Comprehensive Psychiatry. ― 1995. ― Vol. 36. ― №6. ― Р.

397―406.

599. Freedman, R. Cannabis, Inhibitory Neurons and Progressive Course of

Schizophrenia / R. Freedman // Amer. J. Psychiatry. ― 2008. ― Vol. 165. ― P. 490―496.

600. Funk, P. J. Dealing with Psychiatry’s Stigma / J. P. Funk // Hosp. Commun.

Psychiatr. ― 1986. ― №8. ― P. 814―818.

601. Gallohofer, B. Preserving cognitive function-optimization integration into the community / B. Gallohofer // Schizophr. Review. ― 1995. ― Vol. 3. ― №8. ― P. 3―4.

602. Gardos, G. Ten-year outcome of tardive dyskinesia / G. Gardos // Amer. J.

Psychiaty. ― 1994. ― Vol. 151. ― Р. 836―839.

603.Garlic, D. Improving out Outcome in Schizophrenia the Potential Impotance of EPS and Neuroleptic Dysphoria / D. Garlic // Ann. Clin. Psychiatr. ― 2002. ― Vol.

14.― P. 147―152.

604.Giudicelli, S. Hysteries et psychoses / S. Giudicelli // Evolut. Psychiatr. ―

1986. ― №3. ― P. 639―669.

285

605. Gold, J. M. Cognitive deficit in Schizophrenia / J. M. Gold, P. D. Harvey //

Schizophrenia. ― 1993. ― Vol. 16. ― Р. 295―312.

606. Goswami, S. Substance Abusig Schizophrenics: To They Self-Medicate? / S.

Goswami // Am. J. Addict. ― 2004. ― Vol. 13, №2. ― Р. 139―150.

607. Graeff, F. G. Serotonergis System / F. G. Graeff // Psychiatr. Clin. North. Amer.

― 1997. ― Vol. 20. ― P. 23―729.

608. Gredeu, J. Anxiety and Depression Associated with Coffeinism Among Psychiatric Patients / J. Gredeu, P. Fontanc, M. Lubetsky, K. Chamberin // Amer. J.

Psychiatry. ― 1978. ― Vol. 135. ― №8. ― P. 963―966.

609. Gregg, L. Reasons for Increased Substance Use in Psychoses / L. Gregg, C.

Barrowelough // Clinical Psychology Review. ― 2007. ― Vol. 27. ― №4. ― P. 494―510.

610. Griffith, E. H. Psychiatryc Consultation in Catolic Annulment Proceedings / E.

H. Griffith // Hosp. Commun. Psychiatr. ― 1985. ― №4. ― P. 346―347.

611.Gyula, C. A Psyches Iatrogenia a uj Ertelmezes / C.Gyula // Orvoskëpzёs. ― 1975. ― №4. ― S. 286―298.

612.Haan, N. Coping and Defending Process Self-Environment Organization / N.

Haan. ― N.Y. : Academic Press, 1977. ― 296 p.

613. Haghighat, R. A Unitary Theory of Stigmatization. Pursuit of Self-Interest and Routes to Destigmatisation / R. Haghighat // British

Journal of Psychiatry. ― 2001. ― Vol. 178. ― P. 207―215.

614. Hardie, R. J. Neuroleptic-indused Parkinsons Syndrome. Clinical Features and Results of Treatment of Levodopa / R. J. Hardie, A.J. Less // J. Neurol. Neurosurg.

Psychiatr. ― 1988. ― Vol. 51. ― P. 850―854.

615. Hayashi, N. Perceptions of Schizophrenic Patients and their Therapists: Application of the Semantic Differential Technique to Evaluate the Treatment Relationship / N. Hayashi, M. Yomashina, N. Ishige, H. Toguchi, Y. Igarashi // Compr.

Psychiatr. ― 2000. ― Vol. 41, №3. ― Р. 197―205.

286

616.Heim, E. Coping and Adaptivitat: Gibt es Gecigneties oder Ungeeignetes Coping / E. Heim // Psychoter., Psichosom., Med Psychol. ― 1988. ― №1. ― P. 8―17.

617.Hemmings, G. Physical illness in the mentally ill / G. Hemmings // Lancet. ― 1981. ― Vol. 8251. ― Р. 873―875.

618.Henderson, D. C. Clozapin, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study / D. C. Henderson, E. Cagliero, G. Gray //

Amer. J. Psychiaty. ― 2000. ― Vol. 157. ― Р. 975―981.

619. Henquet, C. Gene-Environment Interplay Between Cannabis and Psychosis / C. Henquet, M. Di Forti, P. Morrison, R. Kuepper, R. M. Murray // Schizophrenia Bulletin.

― 2008. ― Vol. 34. ― Р. 1111―1121.

620. Hernacka, B. Dobrowolnosci pszymus hospitalizacji psychiatycznej w swietle materialu kliniki psychiatrycznej am w Poznaniu / B. Hernacka, T. ZakowskaDabrowska // Psychiat. Pol. ― 1973. ― №2. ― S.185―190.

621. Hocking, B. Peducing Illness Stigma and Discrimination / B. Hocking // Medical

Journal. ― 2003. ― Vol. 178. ― P. 47―48.

622.Hofler, A. Quality of Life in Schizophrenia the impact of Psychopathology, Attitude Toward Medication, and Side Effects / A. Hofer // J. Clin. Psychiatry. ― 2004. ― Vol. 65. ― №6. ― Р. 864―866.

623.Holzinger, A. Subjective illness Theory and Antipsychotic Medication

Compliance by Patients with Schizophrenia / A. Holzinger // J. Nerv. Ment. Dis. ― 2002. ― №9. ― Р. 597―603.

624. Horan, W. P. Emotional Responses to Psychosocial Stress in Schizophrenia: the Role of Individual Differences in Affective Traits and Coping / W. P. Horan, J. J.

Blanchard // Schizophrenia Research. ― 2003. ― Vol. 60. ― P. 271.

625. Horan, W. P. Social cognition in schizophrenia, part 2: 12-month stability and prediction of functional outcome in first-episode patients / W. P. Horan, M. F. Green, M. Degroot, A. Fiske, G. Hellemann, K. Kee, R. S. Kern, J. Lee, M. J. Sergi, K. L.

Subotnik // Schizophrenia bulletin. ― 2012. ― Vol. 8. ― P. 865―872.

287

626. Huber, G. Das Koncept substant naher Basis Symptome und seine Bedentung fuer Theoric schizophrer Erkranrunder / G. Huber // Nervarzt. ― 1983. ― Bd. 54. ― №1. ― S. 23―32.

627.Hughes, I. R. Prevalence of Smoking among Psychiatric Outpatients / I. R. Hughes, D. K. Hatsukami, J. E. Metehell, L. A. Dahlgren // Amer. J. Psychiatry. ― 1986. ― Vol. 143. ― №8. ― P. 993―997.

628.Hugheler, J. R. Prevalence of Smoking among Psychiatric Outpatients / J. R. Hugheles, D. K. Hatsukami, J. M. Mitehel., L. A. Dahlgren // Amer. J. Psychiatr. ― 1986. ― Vol. 143. ― №8. ― P. 993―997.

629.Jankovic, J. Tardive syndromes and grug-inducent movement disorder / J.

Jankovic // Clin. Neuropsychopharmacology. ― 1995. ― Vol. 18. ― Р. 197―214. 630. Jarosz, M. Autuzm joko patologiezny mechanism obronny osobowosci / M.

Jarosz // Psychiat. Pol. ― 1979. ― №2. ― S. 111―117.

631. Jensen, M. P. Motivation and Expectancy Factor in Symptom Perception: a Laboratory Study of the Placebo Effect / M. P. Jensen, P. Karoly // Psychosomatic

Medicine. ― 1991. ― Vol. 53. ― P. 144―152.

632.Jeste, D. V. Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients / D. V. Jeste, J. P. Lacro, A. Bailey // J. Am. Geriatr. Soc. ― 1999. ― Vol. 47. ― P. 716―719.

633.Jeste, D. V. Medical comorbidity in schizophrenia / D. V. Jeste, J. A. Gladsjo, L. A. Lindamer, J. P. Lacro // Schizophr Bull. — 1996. — Vol. 22, № 3. — P. 413―430.

634.Jhornicroft, G. Social Deprivation and Rates of Treated Mental Disorders Developing Stratisfical Models to Predict Psychiatric Service Utilization / G.

Jhornicroft // Br. J. Psychiatr. ― 1991. ― Vol. 158. ― P. 475―484.

635. John, M. W. Effects of Smoking on Haloperidol and Reduced Haloperidol Plasma Concentrations and Haloperidol Clearance / M. W. John, S. Saklad, L. Ereshelsky, A.

L. Richards, Ch. M. David // Psychopharmacology. ― 1986. ― Vol. 90. ― №4. ― P. 486―490.

288

636. Johnson, D. A. W. Druginguced psychiatric disorders / D. A. W. Johnson //

Drug. ― 1981. ― Vol. 22. ― №1. ― Р. 57―69.

637. Kapur, S. Clinical and theoreticak implications of 5-HT2, and D2 receptor occupance of clorapinc rispiridone, and olanzapine in schizophrenia / S. Kapur, R. B.

Zipursky, G. Remington // Amer. J. Psychiaty. ― 1999. ― Vol. 156. ― Р. 286―293.

638.Karson, G. Violent Behavior Schizophrenic Impatients / G. Karson, L. B. Bigelow // J. Nerv. Ment. Dis. ― 1987. ― №3. ― P. 161―164.

639.Keck, P. E. Epidemiology of MMS / P. E. Keck, S. L. McElroy, H. G. Pope // J.

Clin. Psychiat. ― 1991. ― Vol. 21. ― Р. 148―151.

640. Keks, N. Impact of Newer Antipsychotics on Outcome in Schizophrenia / N.

Keks // Clin. Therapeutics. ― 1997. ― Vol. 19. ― P. 148―158.

641. Kerwin, R. The answer lies withim selective ligands and pharmacogenomics / R.

Kerwin // Modern Psychiatry Review. ― 2001. ― №8. ― P. 52―55.

642. Kendler, K. A Family Study of the Subtypes of Schizophrenia / K. Kendler, A.

Griuenberg, M. Tsuang // Am. J. Psychiatry. ― 1988. ― Vol. 145. ― P. 57―62.

643. Khamsi, R. Do Coffee and Cigarettes Protect against Parkinson's? / R. Khamsi //

New Scientist. ― 2007. ― №4. ― P. 27―34.

644. King, D. J. The effect of neuroleptics in cognitive and psychomotor function // D.

J. King // Brit. J. Psychiatr. ― Vol.157 ― Р. 799―811.

645. Klein, R. G. Treatment of psychiatric disorders in children and adolescents / R. G. Klein, C. S. Slomkowski // Psychopharmacol. Bull. ― 1993. ― Vol. 29. ― Р.

525―535.

646. Ko, G. N. Prevalenct of tardive dyskinesian Chinese Psychiatri Hospital / G. H.

Ko, L. D. Zvang, W. W. Jan, M. D. Zvang // Amer. J. Psychiaty. ― 1989. ― Vol. 146. ― №3. ― Р. 381―389.

647. Kompman, O. Indicators of Medication Compliance in First-episode Psychosis /

O. Kompman // Psychiatry Res. ― 2000. ― Vol. 110. ― №1. ― Р. 39―48.

289

648. Koran, L. M. Medical evaluation of psychiatric patients Resultats in o State

Mental Health System / L. M. Koran, K. Imai, Th. G. Kelsey, Th. G. Rose, L. C. Levin,

S. Chandra // Arch. Gen. Psychiatry. ― 1989. ― Vol. 46. ― №8. ― Р. 733―740.

649. Koranyi, E. K. Somatic illness in psychiatric patients / E.K. Koranyi /

/Psychosomatics. ― 1980. ― Vol. 21. ― №11. ― Р. 887―891.

650. Kueper, C. Adolescents: Personality and Complaints, Spending of Leisure Time,

Smoking and Drinking / C. Kueper, J. Feij // Tijdschift voor Psychologic. ― 1983. ―

Vol. 11. ― P. 160―181.

651. Lander, G. Uber die psychotherapeutschen wir kingen von Psychopharmaka:

Grundsätzliehe Anmer Kungen aus psychobiologscher / G. Lander // Sieht. Wien. med.

Wschr. ― 1986. ― №19―20. ― S. 491―497.
652.	Laux, G. Long-term use of benzodiazepines in psychiatric patients / G. Laux, W.
Konig // Acta psychiatr. Scand. ― 1987. ― Vol. 76. ― №1. ― Р. 64―70.
653.	Lawrie, S. M. Stigmatisation of Psychiatric Disorder	/ S. M. Lawrie //
Psychiatric Bulletin. ― 1999. ― Vol. 23. ― P. 129―131.
654.	Lazarus, R. S. Emotion and Adaptation / R. S. Lazarus. ―	New-York; Oxford :
Oxford University Press, 1991. ― 117 p.
655.	Lazarus, R. S. Psychological Stress and the Coping Process	/ R. S. Lazarus. ―
New York : McGraw-Hill, 1966. ― 29 p.

656.Lazarus, R. S. Coping and Adaptation / R. S. Lazarus, S. Folkman //The Handbook of Behavioral Medicine / Ed. By W.D. Genry. ― N.Y., 1984. ― 432 p.

657.Lehman, A. F. Convergent Validation of Quality of Life for Persona with Severe Mental Illnesses / A. F. Lehman., L.T. Postrado, L. T. Rashuba // Quality of life

Research. ― 1993. ― №5. ― P. 327―333.

658. Leonard, B. Fundamentals of Psychopharmacology / B. Leonard. ― New-York:

Academical Press, 1998. ― 412 p.

659. Levin, E. D. Nicotinic Interactions with Antipsychotic Drugs, Models of Schizophrenia and Impacts on Cognitive Functions / E. D. Levin, A. H. Rezvani //

Biochem. Pharmacol. ― 2007. ― Vol. 74. ― №8. ― P. 1182―1191.

290

660. Levinson, M. L. Adverse Effects and Drug Interactions Associated with Fluoxetine Therapy / M. L. Levinson, R. J. Lypsy, D. K. Fuller // The Annals of

Pharmacotherapy. ― 1991.―– Vol. 125. ― P. 657―651.

661. Liberman, J. F. Substance abuse comorbidity in schizophrenia /J. L. Liberman ,

M. B. Bowers // Shizophrenia Bull. ― 1990. ― Vol. 16. ― №1. ― Р. 29―30.

662.Liereno, A. Schizophrenia Stigma amond Medical and Nursing Unocreladuates / A. Liereno, M. C. Caceres, E. M. Renas-Ledo // Eur. Psychiatr. ― 2000. ― №5. ― P. 298―299.

663.Link, B. G. On Stigma and its Consequences: Evidence from a Longitudinal Study of Men with Dual Diagnosis of Mental Illness and Substance Abuse / B. G. Link, M. Rahaw, J. C. Phelan // Jornal of Healthond Social Behavior. 1997. ― №38. ― P. ―

177―190.

664. Lipowski, Z. J. Psychosocial Reactions to the Physical Illness / Z. J. Lipowski //

Can. Med. Ass. ― 1983. ― №2. ― P.128―132.

665.Lucas, P. B. Effects of the Acute Administration of Coffeine in Patients with Schizophrenia / P. B. Lucas., D. Pickar., I. Keisoe., M. Rapoport, C. Pato., D. Hommer // Biol. Psychiatry. ― 1990. ― Vol. 28. ― №1. ― P. 35―40.

666.McCabe R. Explanatory Models of Illness in Schizophrenia: Comparison of Four

Ethnic Groups / R. McCabe, S. Priebe // Br J Psychiatry. ― 2004. ― Vol. 185. ― P. 25―30.

667. Manos, N. Discontinuing Antiparkinson Medication in Chronic Schizophrenics.

At what Cost to the Patient / N. Manos, J. Gkiouzepas // Acta Psychiatr. Scand. ― 1981. ― Vol. 63. ― №1. ― P. 28―32.

668. Marks, D. F. Freedom, Responsibility and Power: Contrasting Approaches to

Health Psychology / D. F. Marks // Journal of Health Psychology. ― 2002. ― Vol. 7, №1. ― P. 14―23.

669. Marti-Massó, J. F. Drugs inducing or aggravating parkinsonism: a review / J. F.

Marti-Massó, J. J. Poza, A. L. de Munain // Therapie. ― 1996. ― Vol. 51. ― №5. ―

Р. 568―577.